Nanoparticles of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) for cancer chemotherapy: Preparation, characterization - In-vitro drug release and anti-tumour activity

Journal of Pharmacy and Pharmacology

Volumn 58, Issue 9, 2006, Pages 1177-1181

  Yan, Chengyun ^a,b   Chen, Dawei ^a,b   Gu, Jiwei ^b   Qin, Jing ^a,b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b JIAMUSI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN DERIVATIVE; DRUG CARRIER; FLUOROURACIL; N SUCCINYL CHITOSAN; NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DIFFUSION; DRUG ANALYSIS; DRUG RELEASE; DRUG SYNTHESIS; EMULSION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; SARCOMA; ZETA POTENTIAL;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CHITOSAN; COLLOIDS; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG CARRIERS; DRUG COMPOUNDING; FLUOROURACIL; MICE; MICE, INBRED BALB C; NANOPARTICLES; NEOPLASM TRANSPLANTATION; PARTICLE SIZE; SARCOMA 180; SOLUBILITY; TIME FACTORS;

EID: 33748314588     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.58.9.0003     Document Type: Article

References (28)

1. Barichello, J. M., Morishita, M., Takayama, K., Nagai, T. (1999) Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug. Dev. Ind. Pharm. 25: 471-476
2. Ciftci, K., Hincal, A. A., Kas, S. H., Ercan, T. M., Ruacan, S. (1994) Microspheres of 5-fluorouracil using poly(DL-lactic acid): in vitro release properties and distribution in mace after i.v. administration. Eur. J. Pharm. Sci. 1: 249-258
3. Ciftci, K., Kas, S. H., Hincal, A. A., Ercan, T. M., Ruacan, S., Güven, O. (1996) In vitro and in vivo evaluation of PLAGA (50/50) microspheres containing 5-fluorouracil prepared by a solvent evaporation method. Int. J. Pharm. 131: 73-82
4. Dufes, C., Schatzlein, A. G., Tetley, L., Gray, A. I., Watson, D. G. (2000) Niosomes and polymeric chitosan based vesicles bearing transferring and glucose ligands for drug targeting. Pharm. Res. 17: 1250-1258
5. El-Shabouri, M. H. (2002) Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int. J. Pharm. 249: 101-108
6. Hagiwara, A., Ahn, T., Ueda, T., Iwamoto, A. (1985) Anticancer agents adsorbed by activated carbon particles, a new form of dosage enhancing efficacy on lymphnodal metastases. Anticancer Res. 6: 1005-1008
7. Hejazi, R., Amiji, M. (2003) Chitosan-based gastrointestinal delivery systems. J. Control. Release 89: 151-165
8. Hirano, S. (1999) Chitin and chitosan as novel biotechnological materials. Polym. Int. 48: 732
9. Hirao, E., Saito, T., Kobayashi, M. (1993) Selective delivery of pepleomycin to esophageal lymph nodes by activated carbon particles. Anticancer Res. 13: 991-994
10. Jeyanthi, R., Rao, P. (1989) Release characteristics of bleomycin, mitomycin C and 5-fluorouracil from gelatin microspheres. Int. J. Pharm. 55: 31-37
11. Kato, Y., Onishi, H., Machida, Y. (2000) Evaluation of N-succinyl-chitosan as a systemic long-circulating polymer. Biomaterials 21: 1579-1585
12. Kato, Y., Onishi, H., Machida, Y. (2002a) Tumou cell uptake of lactosaminated and intact N-succinyl-chitosans and antitumour effects of conjugates with mitomycin C. Anticancer Res. 22: 2771-2776
13. Kato, Y., Onishi, H., Machida, Y. (2002b) Efficacy of lactosaminated and intact N-succinylchitosan-mitomycin C conjugates against M5076 liver metastatic cancer. J. Pharm. Pharmacol. 54: 529-537
14. Kim, Y. H., Gihm, S. H., Park, C. R., Lee, K. Y., Kim, T. W. (2001) Structural characteristics of size-controlled self-aggregates of deoxycholic acid-modified chitosan and their application as a DNA delivery carrier. Bioconjugate Chem. 12: 932-938
15. Koping-Hoggard, M., Tubulekas, I., Guan, H., Edwards, K., Nilsson, M. (2001) Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther. 8: 1108-1121
16. Lee, K. Y., Kim, J. H., Kwon, I. C. (2000) Self-aggregates of deoxycholic acid-modified chitosan as a novel carrier of adriamycin. Colloid Polym. Sci. 278: 1216-1219
17. Molinaro, G., Leroux, J., Damas, J., Adam, A. (2002) Biocompatibility of thermosensitive chitosan-based hydrogels: an in vivo experimental approach to injectable biomaterials. Biomaterials 23: 2717-2722
18. Muranishi, S., Fujita, T., Masahiro, M., Yamamoto, A. (1997) Potential for lymphatic targeting of peptides. J. Control. Release 46: 157-164
19. Nakamoto, Y., Hashida, M., Muranishi, S., Sezaki, H. (1975) Studies on pharmaceutical modification of anticancer agents. II Enhanced delivery of bleomycin into lymph by emulsions and drying emulsions. Chem. Pharm. Bull. 25: 2410-2418
20. Nichifor, M., Schacht, E. H., Seymor, L. W. (1997) Polymeric prodrugs of 5-fluorouracil. J. Control. Release 48: 165-178
21. Omotosho, J. A., Whateley, T. L., Law, T. K., Florence, A. T. (1986) The nature of the oil phase and the release of solutes from multiple (w/o/w) emulsions. J. Pharm. Pharmacol. 38: 865-870
22. Onishi, H., Takahashi, H., Yoshiyasu, M., Machida, Y. (2001) Preparation and in vitro properties of N-succinylchitosan- or carboxymethylchitin-mitomycin C conjugate microparticles with specified size. Drug. Dev. Ind. Pharm. 27: 659-667
23. Park, J. H., Cho, Y. W., Chung, H., Kwon, I. C., Jeong, S. Y. (2003) Synthesis and characterization of sugar-bearing chitosan derivatives: aqueous solubility and biodegradability. Biomacromolecules 4: 1087-1091
24. Roy, K., Mao, H. Q., Huang, S. K., Leong, K. W. (1999) Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med. 5: 380-381
25. Ruel-Gariepy, E., Leclair, G., Hildgen, P., Gupta, A., Leroux, J. C. (2002) Thermosensitive chitosan-based hydrogel containing liposomes for the delivery of hydrophilic molecules. J. Control. Release 82: 373-383
26. Son, Y. J., Jang, J. S., Cho, Y. W., Chung, H., Park, R. W. (2003) Biodistribution and anti-tumor efficacy of doxorubicin loaded glycolchitosan nanoaggregates by EPR effect. J. Control. Release 91: 135-145
27. Song, Y., Onishi, H., Machida, Y. (1992) Synthesis and drug-release characteristics of the conjugates of mitomycin C with N-succinyl-chitosan and carboxymethyl-chitin. Chem. Pharm. Bull. 40: 2822-2825
28. Song, Y., Onishi, H., Nagai, T. (1993) Pharmacokinetic characteristics and antitumor activity of the N-succinyl-chitosan-mitomycin C conjugate and the carboxymethyl-chitin-mitomycin C conjugate. Biol. Pharm. Bull. 16: 48-54